Navamedic launches Eroxon[®] in Finland

Oslo, 6 November 2024 – Building on the successful product launch of Eroxon® in Norway and Sweden earlier this year, Navamedic

READ MORE

Navamedic ASA: Invitation to 2024 3rd quarter presentation

Oslo, October 28, 2024 – Navamedic ASA (OSE: Nava) will be presenting its 3rd quarter 2024 results on Thursday, October

READ MORE

Navamedic wins joint Nordic antibiotics tender

Oslo, 07 October 2024 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals

READ MORE